Article
The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS-BPH).
Andrology - 1 Jul 2018
Chen Z P, Yan Y, Chen C J, Li M, Chen C, Zhao S C, Song T, Liu T, Zou C H, Xu Q, Li X
Abstract excerpt
Studies have shown that 48.59% of benign prostate hyperplasia (BPH) is combined with metabolic syndrome (MetS). The mainstream view supports the correlation between MetS and BPH, but the pathogenesis of MetS-BPH is not fully understood. Four hundred and seventy-four men, aged 47 years or older, were recruited into this study by consecutive routine physical examination programs, and several parameters were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.